已收盤 11-20 16:00:00 美东时间
+1.610
+1.71%
Anyone interested in U.S. Physical Therapy, Inc. ( NYSE:USPH ) should probably be aware that the Chief Operating...
11-20 18:04
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从39美元升至40美元;HC Wainwright & Co.:维持Fractyl Health"买入"评级,目标价从8美元升至24美元
11-16 20:14
今日重点评级关注:瑞银:维持Liberty Media"中性"评级,目标价从110美元升至1116美元;杰富瑞:维持伊诺维奥制药"买入"评级,目标价从3美元升至8美元
11-09 14:00
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $98 to $110.
11-07 04:04
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.76 by 5.26 percent. This is a 21.21 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $222.558 millio...
11-05 05:23
今日重点评级关注:Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从10美元升至10.5美元;摩根士丹利:维持Aurora Innovation"超配"评级,目标价从14美元升至18美元
09-14 16:05
JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $90 to $95.
09-12 00:16
今日重点评级关注:HC Wainwright & Co.:维持Innate Pharma"买入"评级,目标价从5美元升至7美元;HC Wainwright & Co.:维持Immix Biopharma"买入"评级,目标价从20美元升至25美元
08-11 11:45
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and raises the price target from $90 to $98.
08-10 20:35
今日重点评级关注:Jones Trading:维持Definium Therapeutics"买入"评级,目标价从61美元升至74美元;韦德布什:维持Cerebras Systems"跑赢大市"评级,目标价从270美元升至280美元
06-25 11:32